Clinical applications of anticancer drugs targeted to topoisomerase II
- 1 October 1998
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression
- Vol. 1400 (1-3), 173-184
- https://doi.org/10.1016/s0167-4781(98)00134-1
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Antitopoisomerase drug action and resistanceEuropean Journal Of Cancer, 1996
- Topoisomerase InhibitorsDrugs, 1995
- Potential Role of Oral Anthracyclines in Older Patients with CancerDrugs & Aging, 1994
- Detection and treatment of testicular cancerCA: A Cancer Journal for Clinicians, 1993
- EpirubicinDrugs, 1993
- Randomized Trial of Doxorubicin, Bisantrene, and Miltoxantrone in Advanced Breast Cancer: A Southwest Oncology Group StudyJNCI Journal of the National Cancer Institute, 1991
- MitoxantroneDrugs, 1991
- Etoposide (VP-16–213)New England Journal of Medicine, 1985
- Inhibition of the DNA catenation activity of type II topoisomerase by VP16-213 and VM26Biochemical and Biophysical Research Communications, 1984
- Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor ResponseScience, 1977